Post Profile






In rare disorder, novel agent stops swelling before it starts

(The Mount Sinai Hospital / Mount Sinai School of Medicine) Mount Sinai researcher who treats hereditary angioedema says the drug, a potential game changer, is being studied in larger clinical trial.
read more

share

Related Posts


Rejected Alzheimer's Drug Shows New Potential in Animal Model

Health : Newswise Medical News

An international team of scientists led by researchers at Mount Sinai School Medicine have discovered that a drug that had previously yielded conflicting results in clinical trials for Alzheimer's disease effectively stopped the pro...

Mount Sinai First to Use Visually Guided Catheter Ablation System to Treat Atrial Fibrillation Patient in New U.S. Clinical Trial

Health : Newswise Medical News

For the first time in a new U.S. clinical trial, researchers at Mount Sinai School of Medicine have used the HeartLight Endoscopic Ablation System (EAS) to correct abnormal electrical signals inside the heart of a patient affected b...

Mount Sinai researchers involved in successful phase 3 trial of drug for liver cancer

Health : EurekAlert: Health

(The Mount Sinai Hospital / Mount Sinai School of Medicine) An international phase 3 trial has found that the drug regorafenib improved survival in patients with advanced hepatocellular carcinoma, a form of liver cancer, giving peop...

Clinical trial supports use of novel preventive therapy for dangerous swelling disorder

Health : EurekAlert: Health

(Massachusetts General Hospital) A clinical trial for a new drug to prevent attacks of hereditary angioedema -- a rare disorder characterized by recurrent swelling of tissues in the face, hands, gastrointestinal tract and airway -- ...

In Rare Disorder, Novel Agent Stops Swelling Before It Starts

Health : Newswise Medical News

Mount Sinai researcher who treats hereditary angioedema says the drug, a potential game changer, is being studied in larger clinical trial

Comments


Copyright © 2016 Regator, LLC